Evidence map›Paper›PMID 36052232›Full record

ArticleFrontiers in oncology2022

One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life.

Katarina Veličković, Carl A K Borrebaeck, Pär-Ola Bendahl, Cecilia Hegardt, Per Johnsson, Corinna Richter, Lisa Rydén, Ingalill Rahm Hallberg

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03430492 (The Molecular Fingerprint of Psychological Resilience - Implications for Diagnostic and Therapeutic Strategies), which is not on this map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03430492 active not recruitingnot on this map

The Molecular Fingerprint of Psychological Resilience - Implications for Diagnostic and Therapeutic Strategies

TypeobservationalSponsorLund UniversityRan2016 to 2025Enrolled985ConditionsBreast Cancer
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. The relationship between sleep quality and emotional resilience in breast cancer patients undergoing chemotherapy: a national cross-sectional study in Iraq.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katarina VeličkovićDepartment of Psychology, Lund University, Lund, Sweden.
Carl A K BorrebaeckDepartment of Immunotechnology and CREATE Health Translational Cancer Center, Lund University, Lund, Sweden.
Pär-Ola BendahlDepartment of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
Cecilia HegardtDepartment of Clinical Sciences Lund, Division of Oncology, Lund University, Lund, Sweden.
Per JohnssonDepartment of Psychology, Lund University, Lund, Sweden.
Corinna RichterDepartment of Immunotechnology and CREATE Health Translational Cancer Center, Lund University, Lund, Sweden.
Lisa RydénDepartment of Clinical Sciences Lund, Division of Surgery, Lund University, Lund, Sweden.
Ingalill Rahm HallbergDepartment of Health Sciences, Lund University, Lund, Sweden.
Lund University · SESkåne University Hospital · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: This study investigated the changes in health-related quality of life from diagnosis to 1 year after diagnosis in breast cancer (BC) patients and the influence of clinical, psychological, and sociodemographic variables. An additional aim was to explore the mediating and moderating effects of resilience on changes in health-related quality of life. Methods: A longitudinal population-based study was conducted in southern Sweden. Newly diagnosed BC patients filled in measures of health-related quality of life, resilience, and sociodemographic variables at diagnosis ( Results: Most health-related quality of life outcomes declined from diagnosis to 1 year post-diagnosis. Role limitations due to emotional problems remained the same, whereas mental health improved. Lower health-related quality of life outcomes were associated with symptomatic detection and axillary dissection. Patients with a higher TNM stage and histologic grade and estrogen receptor (ER)-negative and human epidermal growth factor 2 (HER2)-positive status, who received chemotherapy, antibody therapy, or bisphosphonate therapy, had a steeper decline in outcomes. Changes in resilience were positively associated with all outcomes but did not mediate or moderate changes in any. Resilience at baseline moderated changes in bodily pain, vitality, and mental health, with higher baseline resilience being associated with a steeper decline, possibly due to floor or ceiling effects. Patients with lower socioeconomic status, educational level, and older age had a lower health-related quality of life. Conclusion: Physical health-related quality of life among breast cancer patients declined 1 year post-diagnosis, whereas mental health-related quality of life improved. Low resilient patients may be especially vulnerable at diagnosis. Biopsychosocial assessment at diagnosis can help identify patients who may require additional support. A multidimensional treatment plan should be started early to help overcome the problems in everyday activities.

Indexed as

biopsychosocial (BPS) modelbreast cancerbreast cancer treatmenthealth-related quality of life (HRQL)longitudinal studymultidisciplinarypsychological resiliencetumor characteristics

Identifiers

PMID36052232
PMCPMC9425776
OpenAlexW4291954871

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.